MedPath

Evaluation of External Application of Varnyakar Lepa and Leech therapy in Vyanga(Melasma)

Phase 2/3
Not yet recruiting
Conditions
Other melanin hyperpigmentation. Ayurveda Condition: VYANGAH,
Registration Number
CTRI/2024/02/062768
Lead Sponsor
DrPratiksha Dundappa Talawar
Brief Summary

In Ayurveda skin diseases are included under the headings of Kshudrarogas and Kushta. Sushrutacharya was the first Acharya who had given detailed

describtion of Vyang under the chapter of “Kshudrarogaâ€.The clinical feature of Vyanga can be correlated with Melasma which is one of the common hyper pigmented disorders. The melasma is harmless condition, progression can be cosmetically and psychologically overwhelming.

Treating Melasma in modern science has become a problem and safe drugs for long term therapy are not available in modern medicine.There are treatments available but they may not have impact on malasma or clear it up completely,so its important to know what you can do to help minimize the appearance of dark spots & prevent them from getting worse.Topical steroids have been described in the management of facial melanosis  and these steroids have adverse effect.

According to Acharya Sushrut, Krodh and Shok are causative factors for development of Vyanga as these psychological factors vitiate Pitta and Vata dosha leads to develop Shyava varna mandala on face. Bhrajak pitta is important in production of varna in Avabhasini twacha (one of layer of skin).Vitiation of Pitta dosha in Vyanga, leads to Rakta dusthi producing vikruti in skin colour. In the context of Vyanga both Shodhana and local application in the form of lepa are explained. For Local application ingredients of Varnya mahakashyaya will be taken. In Ashtang Hriday, Raktamokshan chikitsa is described in the treatment of Vynaga.Jaluakawacharan (Leech Therapy) is one of the type of raktamokshan. For this study total 35 patients will be taken & duration of study is two months.An attempt will be made to evaluate efficacy of Jalaukawachran with varnyakar lepa in vyanga w.s.r.Malesma. Results will be discussed according to data.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria
  • 1 Patients with signs & symptoms of Vyanga.
  • 2 Signs & symptoms of Melasma.
Exclusion Criteria

1 Known case of any active skin malignancy 2 Pregnant woman 3 Patients suffering from all major systemic diseases IHD HIV Carcinoma 4 Patients having contagious infectious disease such as active tuberculosis Hepatitis B and C 5 Cases of burn & any skin allergy 6 Any lesion of other skin disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate effect of Jalaukawacharan & Varnykar lepa in Vyanga (melasma) on the basis if assessment criteria of colour of melasma size of lesion & MASI score.Follow up- 1st,15th, 30th ,45 th ,60 th day
Secondary Outcome Measures
NameTimeMethod
To observe the recurrence of melasmaAfter leech application- 30th,45th, 60th day

Trial Locations

Locations (1)

Dr.J.J.Magdum Ayurved Medical college Jaysingpur

🇮🇳

Kolhapur, MAHARASHTRA, India

Dr.J.J.Magdum Ayurved Medical college Jaysingpur
🇮🇳Kolhapur, MAHARASHTRA, India
DrPratiksha Dundappa Talawar
Principal investigator
8975166148
dr.pratiksha2009@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.